Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats.
Saved in:
| Title: | Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats. |
|---|---|
| Authors: | Li J; Laboratories of Neuroimmunology, Department of Symptom Research, The University of Texas, Houston, Texas, USA., Stratton HJ; Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, USA., Lorca SA; Laboratories of Neuroimmunology, Department of Symptom Research, The University of Texas, Houston, Texas, USA., Grace PM; Laboratories of Neuroimmunology, Department of Symptom Research, The University of Texas, Houston, Texas, USA., Khanna R; Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, USA.; Comprehensive Pain and Addiction Center, The University of Arizona, Tucson, Arizona, USA. |
| Source: | Channels (Austin, Tex.) [Channels (Austin)] 2022 Dec; Vol. 16 (1), pp. 1-8. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101321614 Publication Model: Print Cited Medium: Internet ISSN: 1933-6969 (Electronic) Linking ISSN: 19336950 NLM ISO Abbreviation: Channels (Austin) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1933-6969 |
|---|---|
| DOI: | 10.1080/19336950.2021.2023383 |
